-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $42

Benzinga·01/29/2026 14:11:02
Listen to the news
Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $41 to $42.